Translating Ideas into Commercial Biomaterial Devices: A Path to Improving Healthcare.
biomaterial devices
commercialization pathways
healthcare innovation
industry-academia partnerships
translation process
Journal
ACS biomaterials science & engineering
ISSN: 2373-9878
Titre abrégé: ACS Biomater Sci Eng
Pays: United States
ID NLM: 101654670
Informations de publication
Date de publication:
07 Mar 2024
07 Mar 2024
Historique:
medline:
7
3
2024
pubmed:
7
3
2024
entrez:
7
3
2024
Statut:
aheadofprint
Résumé
The medical device industry is undergoing substantial transformations, looking to face the increasing pressures on healthcare systems and fundamental shifts in healthcare delivery. There is an ever-growing emphasis on identifying underserved clinical requirements and enhancing industry-academia partnerships to accelerate innovative solutions. In this context, an analysis of the requirements for translation, highlighting support and funding for innovation to transform an idea for a biomaterial device into a commercially available product, is discussed.
Identifiants
pubmed: 38452343
doi: 10.1021/acsbiomaterials.3c01441
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM